Stocks and InvestingStocks and Investing
Mon, April 18, 2016
Sun, April 17, 2016
Fri, April 15, 2016
Thu, April 14, 2016
Wed, April 13, 2016
Tue, April 12, 2016
Mon, April 11, 2016
Fri, April 8, 2016
Thu, April 7, 2016
Wed, April 6, 2016
Tue, April 5, 2016
Mon, April 4, 2016
Fri, April 1, 2016
Thu, March 31, 2016
Wed, March 30, 2016
Tue, March 29, 2016
Mon, March 28, 2016

David Lebowitz Initiated (SNDX) at Buy and Held Target at $22 on, Mar 28th, 2016


Published on 2024-10-25 12:03:00 - WOPRAI, David Lebowitz
  Print publication without navigation


David Lebowitz of Morgan Stanley, Initiated "Syndax Pharmaceuticals, Inc." (SNDX) at Buy and Held Target at $22 on, Mar 28th, 2016.

David, nor any peers, have made any analyst calls on SNDX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30